EDISON, N.J.--(BUSINESS WIRE)--HealthEC, a leading healthcare technology company, today announced that it has secured additional financing from HLM Venture Partners and the Labcorp Venture Fund. The company also announced a new CEO and Chairman.
Customers rely on HealthEC’s award winning AI-enabled Population Health Management platform to predict and improve health outcomes, maximize quality improvement, and reduce costs. This latest round of capital allows the company to aggressively pursue new healthcare value-based care opportunities while also expanding their behavioral health management platform.
Healthcare technology veteran Chris Caramanico has been tapped as HealthEC’s new Chief Executive Officer. Chris previously served as CEO of Orthus Health where he led strategic oversight, growth, and business operations efforts for the company.
“I am honored to lead this organization at such an exciting and pivotal time in healthcare,” expressed Caramanico. “As the industry and value-based initiatives evolve and expand, this additional funding guarantees that HealthEC will remain at the forefront.”
Arthur Kapoor, founding CEO, will continue to serve as a board member and advisor to help the company and its work in the behavioral health marketplace. Steve Tolle, advisor to HLM Venture Partners, will assume role of chairman.
HealthEC, LLC, the 2019 & 2022 Best in KLAS provider of population health management solutions and leader in and health digital transformation, is on a mission to help its customers succeed with value-based care. HealthEC®, a single-platform solution, enables personalized healthcare by leveraging the power of connectivity and interoperability: connecting claims and clinical systems, enabling data-driven collaboration between payers and providers, and streamlining care coordination across the healthcare landscape. Organizations are empowered with comprehensive analytics and integrated, role-based tools that translate insights into strategies, address care gaps, and improve quality metrics. To learn more, visit us at HealthEC.com, Twitter, LinkedIn, and Facebook.
About HLM Venture Partners
Founded in 1983, HLM is a leading Boston-based healthcare venture investment firm focused on expansion stage opportunities across services and technology companies. Past investments include Teladoc (IPO), Phreesia (IPO), AbleTo (acquired by Optum), and RubiconMD (acquired by Oak Street Health). Selected recent investments include Wayspring, CareBridge, and Main Street Health.